Wakamoto Pharmaceutical Co.,Ltd. (4512.T)
JPY 309.0
(6.92%)
JPY 309.0
(6.92%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 3.54 Billion JPY | -13.81% |
| 2022 | 4.1 Billion JPY | -5.69% |
| 2021 | 4.35 Billion JPY | -2.94% |
| 2020 | 4.48 Billion JPY | -27.55% |
| 2019 | 6.19 Billion JPY | 1.23% |
| 2018 | 6.11 Billion JPY | 0.56% |
| 2017 | 6.08 Billion JPY | 3.86% |
| 2016 | 5.85 Billion JPY | -6.67% |
| 2015 | 6.27 Billion JPY | 7.53% |
| 2014 | 5.83 Billion JPY | 4.19% |
| 2013 | 5.6 Billion JPY | 5.59% |
| 2012 | 5.3 Billion JPY | 4.43% |
| 2011 | 5.08 Billion JPY | -1.84% |
| 2010 | 5.17 Billion JPY | -8.9% |
| 2009 | 5.68 Billion JPY | -8.75% |
| 2008 | 6.22 Billion JPY | -6.12% |
| 2007 | 6.63 Billion JPY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 928.49 Million JPY | -22.59% |
| 2023 Q1 | 874.25 Million JPY | -27.11% |
| 2023 FY | 3.54 Billion JPY | -13.81% |
| 2023 Q4 | 1.19 Billion JPY | 26.26% |
| 2023 Q3 | 949.96 Million JPY | 31.05% |
| 2023 Q2 | 724.89 Million JPY | -17.08% |
| 2022 Q3 | 1.04 Billion JPY | 17.44% |
| 2022 FY | 4.1 Billion JPY | -5.69% |
| 2022 Q4 | 1.19 Billion JPY | 15.21% |
| 2022 Q2 | 886.55 Million JPY | -9.62% |
| 2022 Q1 | 980.87 Million JPY | -12.9% |
| 2021 Q3 | 1.18 Billion JPY | 18.98% |
| 2021 FY | 4.35 Billion JPY | -2.94% |
| 2021 Q4 | 1.12 Billion JPY | -4.83% |
| 2021 Q1 | 1.05 Billion JPY | -7.26% |
| 2021 Q2 | 994.53 Million JPY | -5.45% |
| 2020 Q3 | 1.24 Billion JPY | 20.86% |
| 2020 Q2 | 1.02 Billion JPY | -5.39% |
| 2020 Q1 | 1.08 Billion JPY | -20.73% |
| 2020 Q4 | 1.13 Billion JPY | -8.62% |
| 2020 FY | 4.48 Billion JPY | -27.55% |
| 2019 Q1 | 1.63 Billion JPY | 5.33% |
| 2019 FY | 6.19 Billion JPY | 1.23% |
| 2019 Q2 | 1.41 Billion JPY | -13.67% |
| 2019 Q3 | 1.77 Billion JPY | 25.82% |
| 2019 Q4 | 1.36 Billion JPY | -22.93% |
| 2018 Q4 | 1.55 Billion JPY | -6.55% |
| 2018 FY | 6.11 Billion JPY | 0.56% |
| 2018 Q1 | 1.55 Billion JPY | 10.62% |
| 2018 Q3 | 1.66 Billion JPY | 23.46% |
| 2018 Q2 | 1.34 Billion JPY | -13.61% |
| 2017 Q4 | 1.4 Billion JPY | -18.03% |
| 2017 Q2 | 1.4 Billion JPY | -9.84% |
| 2017 FY | 6.08 Billion JPY | 3.86% |
| 2017 Q1 | 1.55 Billion JPY | 8.68% |
| 2017 Q3 | 1.71 Billion JPY | 22.51% |
| 2016 FY | 5.85 Billion JPY | -6.67% |
| 2016 Q1 | 1.55 Billion JPY | 7.96% |
| 2016 Q3 | 1.57 Billion JPY | 21.4% |
| 2016 Q2 | 1.29 Billion JPY | -16.42% |
| 2016 Q4 | 1.43 Billion JPY | -9.18% |
| 2015 Q3 | 1.77 Billion JPY | 22.81% |
| 2015 Q4 | 1.43 Billion JPY | -18.89% |
| 2015 FY | 6.27 Billion JPY | 7.53% |
| 2015 Q1 | 1.62 Billion JPY | 13.59% |
| 2015 Q2 | 1.44 Billion JPY | -10.9% |
| 2014 Q4 | 1.42 Billion JPY | -14.41% |
| 2014 FY | 5.83 Billion JPY | 4.19% |
| 2014 Q3 | 1.66 Billion JPY | 27.5% |
| 2014 Q2 | 1.3 Billion JPY | -8.98% |
| 2014 Q1 | 1.43 Billion JPY | 3.63% |
| 2013 Q3 | 1.59 Billion JPY | 31.01% |
| 2013 Q4 | 1.38 Billion JPY | -12.83% |
| 2013 FY | 5.6 Billion JPY | 5.59% |
| 2013 Q1 | 1.41 Billion JPY | -8.16% |
| 2013 Q2 | 1.21 Billion JPY | -14.09% |
| 2012 Q3 | 1.4 Billion JPY | 24.8% |
| 2012 Q4 | 1.53 Billion JPY | 9.46% |
| 2012 FY | 5.3 Billion JPY | 4.43% |
| 2012 Q1 | 1.23 Billion JPY | 1.54% |
| 2012 Q2 | 1.12 Billion JPY | -8.89% |
| 2011 FY | 5.08 Billion JPY | -1.84% |
| 2011 Q1 | 1.33 Billion JPY | -3.32% |
| 2011 Q2 | 1.19 Billion JPY | -10.54% |
| 2011 Q3 | 1.32 Billion JPY | 11.15% |
| 2011 Q4 | 1.21 Billion JPY | -8.45% |
| 2010 FY | 5.17 Billion JPY | -8.9% |
| 2010 Q2 | 1.14 Billion JPY | -9.51% |
| 2010 Q1 | 1.26 Billion JPY | -5.36% |
| 2010 Q3 | 1.38 Billion JPY | 21.41% |
| 2010 Q4 | 1.38 Billion JPY | -0.3% |
| 2009 Q4 | 1.33 Billion JPY | -11.79% |
| 2009 Q1 | 1.3 Billion JPY | -5.06% |
| 2009 FY | 5.68 Billion JPY | -8.75% |
| 2009 Q2 | 1.53 Billion JPY | 17.55% |
| 2009 Q3 | 1.51 Billion JPY | -1.26% |
| 2008 Q4 | 1.37 Billion JPY | -15.51% |
| 2008 Q3 | 1.62 Billion JPY | 1.87% |
| 2008 Q2 | 1.59 Billion JPY | 0.0% |
| 2008 FY | 6.22 Billion JPY | -6.12% |
| 2007 FY | 6.63 Billion JPY | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Pharma Foods International Co., Ltd. | 48.75 Billion JPY | 92.737% |
| Takeda Pharmaceutical Company Limited | 2184.96 Billion JPY | 99.838% |
| Sumitomo Pharma Co., Ltd. | 187.98 Billion JPY | 98.116% |
| Shionogi & Co., Ltd. | 369.08 Billion JPY | 99.041% |
| Nippon Shinyaku Co., Ltd. | 97.01 Billion JPY | 96.35% |
| Kaken Pharmaceutical Co., Ltd. | 38.22 Billion JPY | 90.736% |
| Eisai Co., Ltd. | 586.41 Billion JPY | 99.396% |
| Morishita Jintan Co., Ltd. | 5.99 Billion JPY | 40.966% |
| Hisamitsu Pharmaceutical Co., Inc. | 78.97 Billion JPY | 95.516% |
| Mochida Pharmaceutical Co., Ltd. | 52.07 Billion JPY | 93.2% |
| Fuso Pharmaceutical Industries,Ltd. | 13.51 Billion JPY | 73.804% |
| Nippon Chemiphar Co., Ltd. | 7.73 Billion JPY | 54.241% |
| Tsumura & Co. | 68.81 Billion JPY | 94.855% |
| Kissei Pharmaceutical Co., Ltd. | 37.34 Billion JPY | 90.518% |
| Torii Pharmaceutical Co., Ltd. | 24.79 Billion JPY | 85.718% |
| Towa Pharmaceutical Co., Ltd. | 81.38 Billion JPY | 95.649% |
| Fuji Pharma Co., Ltd. | 16.51 Billion JPY | 78.56% |
| Zeria Pharmaceutical Co., Ltd. | 50.18 Billion JPY | 92.944% |
| KYORIN Holdings, Inc. | 51.4 Billion JPY | 93.111% |
| Taiko Pharmaceutical Co.,Ltd. | 1.07 Billion JPY | -228.16% |
| Daito Pharmaceutical Co.,Ltd. | 9.83 Billion JPY | 64.012% |
| SymBio Pharmaceuticals Limited | 4.41 Billion JPY | 19.727% |
| MedRx Co., Ltd | 26 Million JPY | -13518.646% |
| Mizuho Medy Co.,Ltd. | 8.02 Billion JPY | 55.881% |
| Solasia Pharma K.K. | 337 Million JPY | -950.697% |
| Modalis Therapeutics Corporation | -731 Thousand JPY | 484484.131% |
| ASKA Pharmaceutical Holdings Co.,Ltd. | 30.66 Billion JPY | 88.453% |
| Sawai Group Holdings Co., Ltd. | 54.31 Billion JPY | 93.481% |
| Cyfuse Biomedical K.K. | 37.74 Million JPY | -9281.221% |
| Toho Holdings Co., Ltd. | 112.98 Billion JPY | 96.866% |
| Koa Shoji Holdings Co.,Ltd. | 6.63 Billion JPY | 46.671% |